SCHEMBL6715029

SCHEMBL6715029

COC(=O)C(Cc1ccc(OCCNC(=O)c2ccc(-c3ccccn3)cc2)cc1)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.48
HDAC1 Q13547 1/20 0.46
RAB9A P51151 6/20 0.46
NPC1 O15118 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 2/20 0.46
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
PRSS1 P07477 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
TGFBR1 P36897 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
POLB P06746 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716309 0.92 PPARG (0.50) PPARGHDAC1RAB9ANPC1SMN1; SMN2
SCHEMBL6713087 0.86 PPARG (0.47) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL7227706 0.85 PPARG (0.55) PPARGPPARDPPARA
SCHEMBL6713249 0.84 PPARG (0.43) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6713379 0.84 MAPT (0.45) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6713267 0.84 PPARG (0.52) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6722372 0.83 PPARG (0.52) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6718023 0.83 NPC1 (0.45) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6713340 0.83 NPC1 (0.53) PPARGRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL6717755 0.83 NPC1 (0.48) PPARGRAB9ANPC1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885HDAC1 1857/4885RAB9A 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.